COMP <GO>
SNOA vs INBS // ENTERPRISE SCALE & MARKET CAP
Sonoma Pharmaceuticals Inc. (NASDAQ) VS. Intelligent Bio Solutions Inc. (NASDAQ) • 15-METRIC TALLY: SNOA 4
— INBS 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: INBS
LAST: $1.20 (+5.26%) • MKT CAP: $5.7M
market-cap
$5.7M
LAST: $1.83 (+9.58%) • MKT CAP: $6.1M
market-cap
$6.1M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNOA VS. INBS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SNOA | INBS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.00% | 40.80% | -2.80 | INBS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -12.60% | -60.00% | +47.40 | SNOA | /operating-margins <GO> |
| Net Profit Margin | 0.00% | -60.00% | +60.00 | SNOA | /net-margins <GO> |
| Revenue Growth (YoY) | 36.70% | -1.90% | +38.60 | SNOA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 3/9 | +1.00 | SNOA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.0 | 56.9 | -4.90 | INBS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.7M | $6.1M | -$323.6K | INBS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SNOA REV | INBS REV | SNOA GROSS % | INBS GROSS % | SNOA FCF | INBS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $19.5M | $3.1M | 38.0% | 40.8% | -$4.1M | -$9.9M |
| FY 2024 | $14.3M | $3.1M | 38.2% | 45.8% | -$168.0K | -$9.8M |
| FY 2023 | $12.7M | $1.3M | — | — | -$2.4M | -$7.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNOA // BETA —
INBS // BETA —